Plains GP Holdings LP
F:PG81
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Plains GP Holdings LP
F:PG81
|
US |
|
G
|
GlaxoSmithKline PLC
F:GS7
|
UK |
|
Acarix AB
F:7AC
|
SE |
|
B
|
Baozun Inc
XMUN:2BZA
|
CN |
|
D
|
Dexcom Inc
F:DC4
|
US |
|
C
|
Camping World Holdings Inc
F:C83
|
US |
|
C
|
Churchill Downs Inc
XMUN:CHR
|
US |
|
G
|
GlaxoSmithKline PLC
XHAM:GS7
|
UK |
|
A
|
Ad Pepper Media International NV
SWB:APM
|
DE |
|
Kenvue Inc
F:J4D
|
US |
Wall St Price Targets
PG81 Price Targets Summary
Plains GP Holdings LP
According to Wall Street analysts, the average 1-year price target for PG81 is 10.67 EUR with a low forecast of 8.93 EUR and a high forecast of 12.53 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PG81's stock price target?
Price Target
10.67
EUR
According to Wall Street analysts, the average 1-year price target for PG81 is 10.67 EUR with a low forecast of 8.93 EUR and a high forecast of 12.53 EUR.
What is the Revenue forecast for Plains GP Holdings LP?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 4 years is 5%.
What is the Operating Income forecast for Plains GP Holdings LP?
Projected CAGR
16%
Over the last 14 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 4 years is 16%.
What is the Pre-Tax Income forecast for Plains GP Holdings LP?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Plains GP Holdings LP?
Projected CAGR
61%
Over the last 14 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 4 years is 61%.
